Insider · CIK 0001879281
Abecassis Michael M
Reports to the SEC for 1 company · LAS VEGAS, NV
Transactions
7
Companies
1
Filings
5
CIK
0001879281
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-03-31 | PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-03-31 | PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)J Other | — |
| 2025-12-12 | PMCBPharmaCyte Biotech, Inc.A Award | — |
| 2025-12-12 | PMCBPharmaCyte Biotech, Inc.F Tax Payment | −$17.2K |
| 2025-04-25 | PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-04-30 | PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-11-20 | PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4/AAbecassis Michael M0001683168-26-005621SEC(opens sec.gov)
- 4Abecassis Michael M0001683168-26-002630SEC(opens sec.gov)
- 4Abecassis Michael M0001683168-25-009112SEC(opens sec.gov)
- 4Abecassis Michael M0001683168-24-004915SEC(opens sec.gov)
- 4Abecassis Michael M0001683168-23-008429SEC(opens sec.gov)
Companies
Address
C/O PHARMACYTE BIOTECH, INC. 3960 HOWARD HUGHES PARKWAY, SUITE 500
LAS VEGAS, NV, 89169